You are currently viewing CLASS XII – CHAPTER 10 (NOTES 10.3)

CLASS XII – CHAPTER 10 (NOTES 10.3)

TRANSGENIC ANIMALS

  • Definition:

    • Animals manipulated to possess and express foreign genes termed transgenic animals.
    • Commonly produced in rats, rabbits, pigs, sheep, cows, fish, with mice dominating over 95% of transgenic animals.
  • Purposes and Benefits:

    • 1. Normal Physiology and Development:

      • Design Specificity: Engineered to study gene regulation impact on normal body functions and development.
      • Example: Introduction of genes altering insulin-like growth factor formation for in-depth biological role exploration.
    • 2. Study of Disease:

      • Understanding Genetic Contributions: Transgenic animals serve as models for human diseases, aiding investigation of new treatments.
      • Existing Models: Models for cancer, cystic fibrosis, rheumatoid arthritis, Alzheimer’s, facilitating disease mechanism exploration.
    • 3. Biological Products:

      • Medicine Production: Creation of transgenic animals producing valuable biological products.
      • Examples: Production of human proteins like α-1-antitrypsin for treating emphysema; efforts for treating phenylketonuria (PKU) and cystic fibrosis.
      • Landmark Achievement: Rosie, the first transgenic cow (1997), produced human protein-enriched milk, nutritionally superior for human babies.
    • 4. Vaccine Safety:

      • Reliable Testing: Development of transgenic mice for pre-human vaccine safety testing.
      • Example: Transgenic mice used to test polio vaccine safety, potentially replacing monkey testing.
    • 5. Chemical Safety Testing (Toxicity/Safety Testing):

      • Accelerated Results: Transgenic animals designed to be more sensitive to toxic substances for faster toxicity testing.
      • Efficiency: Facilitates quicker toxicity results compared to non-transgenic animals.